Nalpropion Pharmaceuticals, Inc.
https://www.nalpropion.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nalpropion Pharmaceuticals, Inc.
Novo Nordisk’s Wegovy Gets EU Thumbs Up But Launch Will Wait
Wegovy is set to join Saxenda as the company’s second EU approved drug for obesity, helping it corner the region’s weight-management market, once the company gets its supply back on track.
US FDA Actions On Rx Drug Promos Covered New Territory Last Year
Office of Prescription Drug Promotion issued just six letters citing companies for improper drug promotion in 2020, including the placement of safety information in an email and making unfounded COVID-19 claims. New research projects focus on celebrity endorsements, medical conference materials.
Company Information
- Other Names / Subsidiaries
-
- Currax Pharmaceuticals LLC
- Orexigen Therapeutics, Inc.